Kinnov Therapeutics
PrivateLast Round
Corporate Funding
Apr 1, 2020
Total Funding Raised
$6.56M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kinnov Therapeutics operates in Healthcare & Life Sciences and is based in France. Its latest recorded funding round was a Corporate Funding round in April 2020.
Kinnov Therapeutics is a biotechnology company that develops innovative pharmaceutical treatments for addiction, including its lead candidate KT-110 for alcohol use disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kinnov Therapeutics Comparables
Compare Kinnov Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sobrera Pharma | 86% | |
| Clearmind Medicine Inc. | 79% | |
| Sophrosyne Pharmaceuticals | 77% |
For institutional investors. Book with your work email.
Kinnov Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 1, 2020 | ||||
| Grant | Oct 1, 2019 | ||||
| Seed | Jul 3, 2015 |
For institutional investors. Book with your work email.
Kinnov Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Biocodex | Corporate Funding |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 124% MoM, reaching 1K.
- May 4, 2025
Monthly visitors increased 175% MoM.
For institutional investors. Book with your work email.
Kinnov Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kinnov Therapeutics's valuation, stock price, and market status.
Is Kinnov Therapeutics a public or private company?
Kinnov Therapeutics is a private company.
What is the current stock price of Kinnov Therapeutics?
Kinnov Therapeutics is a private company, so its shares have no public market price. Caplight tracks Kinnov Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kinnov Therapeutics worth (valuation)?
Valuation information for Kinnov Therapeutics is not publicly available.
Can I buy Kinnov Therapeutics stock?
Kinnov Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kinnov Therapeutics's last funding round?
Kinnov Therapeutics's most recent funding round was Corporate Funding on April 1, 2020.
Who are the main investors in Kinnov Therapeutics?
Key investors in Kinnov Therapeutics include European Commission, Biocodex, Bpifrance.
Will Kinnov Therapeutics IPO soon?
No public IPO plans have been announced for Kinnov Therapeutics.
How can I track Kinnov Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kinnov Therapeutics's shares on secondary markets.